Humphrey Jeffrey 4
4 · Magenta Therapeutics, Inc. · Filed Oct 4, 2021
Insider Transaction Report
Form 4
Humphrey Jeffrey
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-10-01+275,000→ 275,000 totalExercise: $7.51Exp: 2031-09-30→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exerciseable over four years, with 25% of this option vesting on October 1, 2022, and the remainder vesting in 36 equal monthly installments thereafter.